BREAKING NEWS! PROVENGE APPROVED!
April 29th, 2010 | Posted by CTL 
Patients, families and doctors can rejoice today as they FINALLY can get access to a safe treatment that will stimulate their immune system to fight prostate cancer. This also opens the door for more similar types of treatments in the war on cancer.
Congratulations to Dendreon for a steadfast mission that overcame more obstacles than Harrison Ford saw in the the movie, “The Fugitive”. Thanks to all CareToLive members and friends who fought for this great day in medical history. Thanks to our Attorney Kerry Donahue for his steadfast devotion to this cause.
LET THE CELEBRATING BEGIN!
DUBLIN, OHIO (CTL) - April 29, 2010 - Today, the Food and Drug Administration finally approved Provenge!!!
FDA NEWS RELEASE
For Immediate Release: April 29, 2010
FDA Approves a Cellular Immunotherapy for Men with Advanced Prostate Cancer
The U.S. Food and Drug Administration today approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm210174.htm
Note: Dendreon logo per www.Dendreon.com
Popularity: 68%
Tags: CareToLive, Celebration, CTL, Dendreon, FDA, Prostate Cancer, provenge
